[go: up one dir, main page]

NO920791D0 - Blanding for stabilisering av blodplasma under pasteurisering - Google Patents

Blanding for stabilisering av blodplasma under pasteurisering

Info

Publication number
NO920791D0
NO920791D0 NO1992920791A NO920791A NO920791D0 NO 920791 D0 NO920791 D0 NO 920791D0 NO 1992920791 A NO1992920791 A NO 1992920791A NO 920791 A NO920791 A NO 920791A NO 920791 D0 NO920791 D0 NO 920791D0
Authority
NO
Norway
Prior art keywords
blood plasma
stabilization
mixture
plasma during
during pasteurization
Prior art date
Application number
NO1992920791A
Other languages
English (en)
Other versions
NO179127B (no
NO920791L (no
NO179127C (no
Inventor
Miryana Burnouf-Radosevich
Thierry Burnouf
Original Assignee
Centre Regional De Transfusion
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Regional De Transfusion filed Critical Centre Regional De Transfusion
Publication of NO920791D0 publication Critical patent/NO920791D0/no
Publication of NO920791L publication Critical patent/NO920791L/no
Publication of NO179127B publication Critical patent/NO179127B/no
Publication of NO179127C publication Critical patent/NO179127C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/104—Aminoacyltransferases (2.3.2)
    • C12N9/1044—Protein-glutamine gamma-glutamyltransferase (2.3.2.13), i.e. transglutaminase or factor XIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0023—Heat
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6443—Coagulation factor XIa (3.4.21.27)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21027—Coagulation factor XIa (3.4.21.27)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • External Artificial Organs (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO920791A 1990-07-03 1992-02-28 Fremgangsmåte for pasteurisering av blodplasma samt blanding for utförelse derav NO179127C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9008375A FR2664165B1 (fr) 1990-07-03 1990-07-03 Composition pour stabiliser le plasma sanguin en cours de pasteurisation.
PCT/FR1991/000493 WO1992000767A1 (fr) 1990-07-03 1991-06-20 Composition pour stabiliser le plasma sanguin en cours de pasteurisation

Publications (4)

Publication Number Publication Date
NO920791D0 true NO920791D0 (no) 1992-02-28
NO920791L NO920791L (no) 1992-02-28
NO179127B NO179127B (no) 1996-05-06
NO179127C NO179127C (no) 1996-08-14

Family

ID=9398269

Family Applications (1)

Application Number Title Priority Date Filing Date
NO920791A NO179127C (no) 1990-07-03 1992-02-28 Fremgangsmåte for pasteurisering av blodplasma samt blanding for utförelse derav

Country Status (22)

Country Link
EP (1) EP0497929B1 (no)
JP (1) JP3132828B2 (no)
AT (1) ATE135238T1 (no)
AU (1) AU8062991A (no)
CA (1) CA2065284A1 (no)
CZ (1) CZ281431B6 (no)
DE (1) DE69117920T2 (no)
DK (1) DK0497929T3 (no)
ES (1) ES2084821T3 (no)
FI (1) FI96918C (no)
FR (1) FR2664165B1 (no)
GR (1) GR3020048T3 (no)
HU (1) HU208404B (no)
LT (1) LT3419B (no)
LV (1) LV10384B (no)
NO (1) NO179127C (no)
PL (1) PL166579B1 (no)
PT (1) PT98190B (no)
RU (1) RU2045902C1 (no)
SK (1) SK279031B6 (no)
WO (1) WO1992000767A1 (no)
ZA (1) ZA914848B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2687317B1 (fr) 1992-02-13 1995-06-23 Aetsrn Composition pour stabiliser le plasma sanguin en cour de pasteurisation et solution plasmatique pasteurisee a usage therapeutique.
DE4240103A1 (de) * 1992-05-26 1993-12-02 Behringwerke Ag Verfahren zur Inaktivierung von Viren in Präparationen von Proteinen
DE19508192A1 (de) 1995-03-09 1996-09-12 Behringwerke Ag Stabile Transglutaminasepräparate und Verfahren zu ihrer Herstellung
US20060019234A1 (en) * 2004-07-22 2006-01-26 Shanbrom Technologies, Llc Modern blood banking employing improved cell preservation composition
WO2017155678A1 (en) 2016-03-10 2017-09-14 Kindheart, Inc Fake blood for use in simulated surgical procedures

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2916711A1 (de) 1979-04-25 1980-11-06 Behringwerke Ag Blutgerinnungsfaktoren und verfahren zu ihrer herstellung
DE3176491D1 (en) 1980-03-05 1987-11-26 Miles Lab Pasteurized therapeutically active protein compositions
DE3045153A1 (de) * 1980-11-29 1982-07-08 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung von blutgerinnungsfaktoren und danach hergestellte praeparation der faktoren ix und x
DE3336631A1 (de) * 1983-10-08 1985-04-18 Behringwerke Ag, 3550 Marburg Verfahren zur pasteurisierung von plasma oder von konzentraten der blutgerinnungsfaktoren ii, vii, ix und x
US4543210A (en) * 1984-10-04 1985-09-24 Miles Laboratories, Inc. Process for producing a high purity antihemophilic factor concentrate
DK18288D0 (da) * 1988-01-15 1988-01-15 Nordisk Gentofte Fremgangsmaade til pasteurisering af vandige oploesninger af faktor viii

Also Published As

Publication number Publication date
WO1992000767A1 (fr) 1992-01-23
FR2664165B1 (fr) 1992-10-16
NO179127B (no) 1996-05-06
NO920791L (no) 1992-02-28
HU208404B (en) 1993-10-28
HUT60148A (en) 1992-08-28
FI96918B (fi) 1996-06-14
ZA914848B (en) 1992-04-29
JPH05501417A (ja) 1993-03-18
FR2664165A1 (fr) 1992-01-10
LT3419B (en) 1995-09-25
DE69117920D1 (de) 1996-04-18
AU8062991A (en) 1992-02-04
EP0497929A1 (fr) 1992-08-12
NO179127C (no) 1996-08-14
LV10384A (lv) 1995-02-20
FI96918C (fi) 1996-09-25
SK279031B6 (sk) 1998-05-06
LV10384B (en) 1995-04-20
RU2045902C1 (ru) 1995-10-20
DE69117920T2 (de) 1996-10-02
GR3020048T3 (en) 1996-08-31
LTIP264A (en) 1994-10-25
ATE135238T1 (de) 1996-03-15
JP3132828B2 (ja) 2001-02-05
EP0497929B1 (fr) 1996-03-13
CZ281431B6 (cs) 1996-09-11
PT98190A (pt) 1992-05-29
CA2065284A1 (fr) 1992-01-04
PL166579B1 (pl) 1995-06-30
DK0497929T3 (da) 1996-07-22
ES2084821T3 (es) 1996-05-16
PL294037A1 (en) 1993-01-11
PT98190B (pt) 1998-12-31
CS57992A3 (en) 1992-08-12
HU9200701D0 (en) 1992-05-28
FI920934A0 (fi) 1992-03-02

Similar Documents

Publication Publication Date Title
NO930473D0 (no) Blanding for stabilisering av blodplasma under pasteurisering
RU93004727A (ru) Состав для стабилизации плазмы крови, способ пастеризации плазмы и использование стабилизированной плазмы в терапии
NO920791D0 (no) Blanding for stabilisering av blodplasma under pasteurisering
IL79910A0 (en) Tricyclic compounds,process for the preparation thereof and pharmaceutical compositions containing the same
DE3173084D1 (en) Use of a substance obtained from blood serum for the stabilization of prostaglandins
DE3464486D1 (en) Derivatives of n-(4-acetylaminophenacyl)-amine, their therapeutical use and process for their preparation
NO933628D0 (no) Fremgangsmaate og blanding for behandling av herpes-infeksjoner

Legal Events

Date Code Title Description
MK1K Patent expired